The immunohistological reactivity of six retinoblastomas was investigated by means of 18 monoclonal antibodies and compared with that of adult and fetal retina. The antigenic profiles were found to be characteristic for each cell type studied and indicated that a panel of monoclonal antibodies could achieve a specific immunolocalisation not clonal antibody was added to each section for 60 minutes at room temperature in a humid chamber, followed by successive 15-minute incubations in secondary rabbit antimouse immunoglobulin (Dako, 1:20 in PBS) and tertiary mouse peroxidase antiperoxidase complex (Dako, 1:40 in PBS). The secondary and tertiary stages were repeated to amplify the binding. The sections were soaked in tris buffered saline (TBS, pH 7-6) for 5 minutes, and incubated with 4-chloro-1-naphthol (10 mg in 100 1I ethanol, added to 25 ml TBS containing 144 group.bmj.com on September 27, 2016 -Published by http://bjo.bmj.com/ Downloaded from
Retinoblastoma is the commonest ocular malignancy of newborn babies and infants. Despite advances in early diagnosis and treatment, the mortality rate due to metastatic spread remains above 15%. It is particularly high in parts of the world where there is a lack of immediate medical care. Although established therapeutic techniques are effective in dealing with most primary malignancies, it is the metastases that kill,' and further techniques must be investigated for their identification and treatment.
The clinical applications of monoclonal antibodies have been explored with regard to the diagnosis and treatment of neuroectodermally derived tumours.'-" A panel of monoclonal antibodies, tailored to the antigenic profile of the tumour, may be used to locate malignant cells in extraocular sites such as cerebrospinal fluid'0 12 and bone marrow, 8 13 '4 and help to determine the extent of metastatic spread. In addition tumourpositive antibodies have potential value in immunotherapy and drug targeting to prevent the dissemination of tumour cells. Knowledge of the immunohistochemical reactivity of the tumour would also provide a useful adjunct to conventional histological classification and assist in assessing the prognosis.
In order to explore these and other potential uses of monoclonal antibodies comprehensive data on the immunochemical reactivity of the tumour are required, and antibodies must be assessed to determine their relative affinity for retinoblastoma and normal ocular tissue.
The histogenesis of retinoblastoma has been the subject of many recent investigations. Histological and microscopic studies have demonstrated characteristics associated with both astrocytic and photoreceptor cells,5 16 and immunohistological investigations using antibodies against antigens associated with specific cell types, such as glial fibrillary acidic protein,'5 17-22 S_100,2o retinal s-antigen, 15 Monoclonal antibodies UJ13A, A2B5, and HI 1 were strongly positive in all retinal tissues and retinoblastoma; M148 and FD19 were moderately positive in all tissues; and UJ127. 11 showed identical distribution to UJ181.4. Antibodies found to be negative throughout were LE61, 2.3F9, UJ167.11, UJ308, and the MI/ N1. The comparative antigen expressions for the other antibodies in the panel are shown in RT97 (neurofilament antigen). This cytoplasmic antigen was expressed in the nerve fibre layer after 12 weeks' gestation, and in mature photoreceptors. Retinoblastoma showed mild affinity for this antibody, though this was particularly sensitive to antibody titre.
UJ7181.4, UJ7127.11 (neuroblastic antigens). In all tissues characterised it was found that these cell surface antigens were expressed in parallel, remaining constant throughout development, and limited primarily to the inner retinal layers. Moderate to intense expression was seen in all the retinoblastomas. BFIO (neurofilament antigen). This cytoplasmic antigen was limited in distribution to the nerve fibre layer of post 11-week retina.
A THY-I (human Thy-i antigen Original magnification x 1000.
neuroblastic cell expressed the thy-i antigen.
Retinoblastoma showed a heterogeneous, medium to strong affinity for this antibody. FD32.2 (human glioma immunogen). Antigen in the adult retina was limited to the photoreceptor layer, and there was a weak to moderate expression throughout fetal retinas of all ages. A marked dissimilarity in the affinity of the adult and fetal choroid/sclera was noted, the adult being substantially more intense. Moderate antigen levels were located in retinoblastoma.
FD44 (human glioma immunogen). The cellular layers of the adult retina displayed a mild affinity for this antibody. There was mild to moderate marking of all fetal layers irrespective of age. A moderate, heterogeneous localization was observed in retinoblastoma. 
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